文献速递血栓与止血

复发/难治性免疫性血小板减少症中骨髓检查的频率与效用

Frequency and utility of bone marrow examination in relapsed/refractory immune thrombocytopenia.
PubMed 文献 · J Thromb Haemost · 2022-07-11

该多中心回顾性队列研究纳入2012至2019年加拿大阿尔伯塔省接受二线治疗的324例成人免疫性血小板减少症(ITP)患者,181例(56%)接受了骨髓检查(BME),异常骨髓发现8例(占总体2%;占BME的4%)。年龄较大、贫血、脾肿大、脾切除及脾切除无应答是BME的显著预测因素,大细胞增多和农村居住是异常骨髓发现的独立预测因素。

要点

  • 324例拟诊ITP成人中181例(56%)接受BME,异常骨髓发现仅8例(总体2%;BME的4%)。
  • 年龄较大、贫血、脾肿大、脾切除及脾切除无应答是BME的显著预测因素。
  • 大细胞增多(aOR 9.6)和农村居住(aOR 6.7)是异常骨髓发现的独立预测因素。

核心结论

  • 尽管在复发/难治性ITP中常规BME实施频繁,但异常发现罕见;未来需前瞻性研究以识别可能从BME获益的复发/难治性ITP亚组。

研究设计与样本

  • 多中心回顾性队列研究,纳入2012至2019年加拿大阿尔伯塔省接受二线治疗的成人ITP患者324例。

主要发现

  • 324例拟诊ITP患者中181例(56%)接受了BME。
  • 过去十年间,60岁以上患者BME率显著下降,而60岁以下患者未见下降。
  • 多因素logistic回归显示,年龄较大(aOR 1.03,p=.0001)、贫血(aOR 2.5,p=.01)、脾肿大(aOR 3.2,p=.01)、脾切除(aOR 2.4,p=.02)及脾切除无应答(aOR 3.4,p=.04)是BME的显著预测因素。
  • 异常骨髓发现8例(占总体2%;占BME的4%):4例骨髓增生异常综合征、1例再生障碍性贫血、1例慢性淋巴细胞白血病、1例转移性癌症、1例巨幼细胞性贫血;其中7例(88%)因双系/全血细胞减少接受BME。
  • 大细胞增多(aOR 9.6,p=.03)和农村居住(aOR 6.7,p=.02)是异常骨髓发现的独立预测因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The diagnosis of immune thrombocytopenia (ITP) is one of exclusion. Although guidelines recommend against routine bone marrow examination (BME) at time of ITP diagnosis, the role of BME in relapsed/refractory ITP is unclear. OBJECTIVES: To examine the frequency and predictors of BME in relapsed/refractory ITP. PATIENTS/METHODS: This multicenter retrospective cohort study included adults with ITP who received second-line therapy in Alberta, Canada from 2012 to 2019. We calculated the frequency of BME and rate of abnormal marrow findings. Logistic regression was performed to assess predictors of BME and predictors of bone marrow pathology. RESULTS: Of 324 patients with presumed ITP, 181 (56%) underwent BME. We observed a marked decline in the rates of BME among patients >60 years over the past decade, but not in patients younger than age 60 years. On multivariable logistic regression, older age (adjusted OR [aOR] 1.03, p = .0001), anemia (aOR 2.5, p = .01), splenomegaly (aOR 3.2, p = .01), splenectomy (aOR 2.4, p = .02), and lack of splenectomy response (aOR 3.4, p = .04) were significant predictors of BME. Abnormal marrow findings were found in eight (2% of overall cohort; 4% of BME): four myelodysplastic syndrome, one aplastic anemia, one chronic lymphocytic leukemia, one metastatic cancer, and one megaloblastic anemia. Seven (88%) underwent BME for bicytopenias/pancytopenias. Macrocytosis (aOR 9.6, p = .03) and rural residence (aOR 6.7, p = .02) were independent predictors of abnormal bone marrow findings. CONCLUSIONS: Although routine BME is frequently performed in relapsed/refractory ITP, abnormal findings are rare. Future prospective studies are needed to help identify a subgroup of relapsed/refractory ITP who may benefit from BME.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Taparia K, Wall E, Arnold DM, et al. Frequency and utility of bone marrow examination in relapsed/refractory immune thrombocytopenia. J Thromb Haemost. 2022. PMID: 35751575. doi:10.1111/jth.15802

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。